Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANS-6637 and Ethanol in Moderate Drinkers
NCT03203499Phase 1Completed
- Sponsor
- Amygdala Neurosciences
- Start
- Feb 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in alcohol use disorder (AUD) comparing ANS-6637 with Placebo (2 arms). Primary endpoint: Incidence and severity of adverse events. Started Feb 2017; status: completed.
02
Drugs
ANS-6637
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03203499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03203499.